Total Nutraceutical Solutions Mushroom Study Reveals Increased Biologic Survival
Agaricus blazei Murill Significantly Increases Survival of Nutritionally Deprived Organism
STEVENSON, Wash., Sep 30, 2009 (BUSINESS WIRE) -- Total Nutraceutical Solutions, Inc. (TNS) (OTCBB:TNUS), announced today that a proprietary grown mushroom, Agaricus blazei Murill (AbM) by Sylvan Bio, Inc. and Creekside Mushrooms Limited, has shown a significant increase in survival of a live biologic model, Drosophila melanogaster (Drosophila).
This study revealed that ingestion of a natural organic edible whole food could increase biologic survival. Unaltered and Vitamin D2 enriched AbM dried powders significantly increased survival above controls, 4% and 15% respectively. The study was performed under contract by Model BioSystems Inc, using a proprietary Drosophila biologic model developed in the laboratory of Dr. Krishna Bhat, University of Texas, Galveston, Texas. This unique live model system can evaluate the effect of a given compound/ingredient for survival on a nutritionally deficient diet. The fruit fly, now a standard model in genetic research, is an ideal research tool since it develops from fertilized egg to embryo within nine days. A special proprietary preparation of AbM was prepared and enriched with Vitamin D2 by exposure to short bursts of pulsed UV light and complete natural dried powders of AbM, unexposed and exposed, were studied in a blinded investigator protocol; the total study involved over 1,000 Drosophila with 120 organisms in each group.
Vitamin D, called the 'sunshine vitamin,' has recently received much attention as a needed nutritional supplement to improve human health. Decreased levels of Vitamin D have been associated with a range of diseases, such as osteoporosis, osteoarthritis, cancer of the breast, diabetes, cardiovascular disease, and many others.
TNS has filed a "Use Patent Application" on these breakthrough nutritional findings with the United States Patent Office.
"The ability of a natural organic whole food, such as Agaricus blazei Murill, to increase biologic survival, is a welcome development in healthcare as more and more people demand natural alternatives to prevent disease and potentially slow down the aging process," stated Marvin S. Hausman MD, CEO, Total Nutraceutical Solutions, Inc. "These new and exciting results have the potential to empower people worldwide with a key wellness tool."
"We believe that the unique, proprietary technology used to produce these mushrooms, contributes significantly to the success of the TNS study," commented Dr. Mark Wach, Sylvan's Vice President and Director of Research. "We are excited about the use of live biologic models in helping to quantify the healthcare potential of our mushroom products."
Sylvan Bio, Inc. is an emerging leader in providing innovative fungal products to a variety of industries. Based in Kittanning, Pennsylvania, it is a wholly owned subsidiary of Sylvan Inc., also based in Kittanning. Sylvan Inc. serves mushroom, agricultural and nutraceutical markets through its prominence in fungal technology and solid-substrate fermentation.
Creekside Mushrooms Limited is the largest single site fully integrated and highly technological "underground" mushroom growing farm in the world. Creekside's unique underground farm is scientifically monitored to provide ideal year-round growing conditions to consistently produce the highest quality mushrooms, which are 100% organic.
